System violated the SDWA by failing to comply with the Stage 2 DBPR MCL requirements for TTHMs for 1st, 2nd, 3rd and 4th quarters of 2014 and 1st quarter of 2015. Cost of on-going release is $10,000, which includes the cost of preparing CAP and treatment change.